These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31583970)

  • 1. Ceftazidime plasma concentration in a patient with cystic fibrosis treated with ceftazidime/avibactam plus trimethoprim/sulfametoxazole for
    Saffioti C; Barco S; Cangemi G; Mesini A; Casciaro R; Cresta F; Castellani C; Bandettini R; Morelli P; Castagnola E
    J Chemother; 2019; 31(7-8):436-438. PubMed ID: 31583970
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series.
    Spoletini G; Etherington C; Shaw N; Clifton IJ; Denton M; Whitaker P; Peckham DG
    J Antimicrob Chemother; 2019 May; 74(5):1425-1429. PubMed ID: 30649419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis.
    Daccò V; Claut L; Piconi S; Castellazzi L; Garbarino F; Teri A; Colombo C
    Transpl Infect Dis; 2019 Jun; 21(3):e13082. PubMed ID: 30892778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime-avibactam.
    Los-Arcos I; Len O; Martín-Gómez MT; González-López JJ; Saéz-Giménez B; Deu M; Nuvials X; Ferrer R; Román A; Gavaldà J
    Infection; 2019 Apr; 47(2):289-292. PubMed ID: 30565008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.
    Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA
    ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Van Dalem A; Herpol M; Echahidi F; Peeters C; Wybo I; De Wachter E; Vandamme P; Piérard D
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
    Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients.
    Farfour E; Trochu E; Devin C; Cardot Martin E; Limousin L; Roux A; Picard C; Jolly E; Vasse M; Lesprit P
    Transpl Infect Dis; 2018 Oct; 20(5):e12955. PubMed ID: 29896802
    [No Abstract]   [Full Text] [Related]  

  • 9. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H; Lenney W; Gilchrist FJ
    BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antibiotic combinations proposed for treatment of
    El-Halfawy OM; Naguib MM; Valvano MA
    Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of resistant Burkholderia multivorans infection in a patient with cystic fibrosis using ceftazidime/avibactam plus aztreonam.
    Barlow G; Morice A
    J Antimicrob Chemother; 2018 Aug; 73(8):2270-2271. PubMed ID: 29912407
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam.
    Tamma PD; Fan Y; Bergman Y; Sick-Samuels AC; Hsu AJ; Timp W; Simner PJ; Prokesch BC; Greenberg DE
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29588357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of
    Schaumburg F; Idelevich EA; Mellmann A; Kahl BC
    Microb Drug Resist; 2022 May; 28(5):545-550. PubMed ID: 35512733
    [No Abstract]   [Full Text] [Related]  

  • 14. Burkholderia cepacia genomovar III and Burkholderia vietnamiensis double infection in a cystic fibrosis child.
    Magalhães M; de Britto MC; Vandamme P
    J Cyst Fibros; 2002 Dec; 1(4):292-4. PubMed ID: 15463830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients.
    Massip C; Mathieu C; Gaudru C; Miaut V; Floch P; Oswald E; Segonds C; Guet-Revillet H
    J Antimicrob Chemother; 2019 Feb; 74(2):525-528. PubMed ID: 30312409
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil.
    da Costa Capizzani CP; Caçador NC; Torres LAGMM; Tonani L; Vandamme P; da Costa Darini AL
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2263-2271. PubMed ID: 28840370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?
    Ball R; Brownlee KG; Duff AJ; Denton M; Conway SP; Lee TW
    J Cyst Fibros; 2010 Jan; 9(1):73-4. PubMed ID: 19932062
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Mazer DM; Young C; Kalikin LM; Spilker T; LiPuma JJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?
    Etherington C; Peckham DG; Conway SP; Denton M
    J Cyst Fibros; 2003 Dec; 2(4):220-1. PubMed ID: 15463878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.